norspan 30 mikrogramm/h transdermales pflaster
mundipharma gmbh - buprenorphin - transdermales pflaster - 30 mikrogramm - analgetika, opioide - behandlung von mittelstarken nicht-malignen schmerzen, wenn ein opioid zum erreichen einer adäquaten analgesie notwendig ist. norspan ist nicht zur behandlung akuter schmerzen geeignet. norspan wird angewendet bei erwachsenen.
norspan
mundipharma pty ltd - buprenorphine -
norspan
mundipharma new zealand ltd - buprenorphine 10mg; ; - transdermal patch - 10 mg - active: buprenorphine 10mg excipient: polyacrylate. durotak 387.2054 and durotak 387.2051 levulinic acid oleyl oleate povidone - management of moderate to severe pain.
norspan
mundipharma new zealand ltd - buprenorphine 20mg; ; - transdermal patch - 20 mg - active: buprenorphine 20mg excipient: polyacrylate. durotak 387.2054 and durotak 387.2051 levulinic acid oleyl oleate povidone - management of moderate to severe pain.
norspan
mundipharma new zealand ltd - buprenorphine 5mg; ; - transdermal patch - 5 mg - active: buprenorphine 5mg excipient: polyacrylate. durotak 387.2054 and durotak 387.2051 levulinic acid oleyl oleate povidone - management of moderate to severe pain.
norspan forðaplástur 10 míkróg/klst.
mundipharma a/s - buprenorphinum inn - forðaplástur - 10 míkróg/klst.
norspan forðaplástur 20 míkróg/klst.
mundipharma a/s - buprenorphinum inn - forðaplástur - 20 míkróg/klst.
norspan forðaplástur 5 míkróg/klst.
mundipharma a/s - buprenorphinum inn - forðaplástur - 5 míkróg/klst.
norspan
mundipharma ges.m.b.h - buprenorfinas - transderminis pleistras - 10 µg/val.; 5 µg/val.; 20 µg/val. - buprenorphine
norspan 20 mikrogrami/stundā transdermāls plāksteris
mundipharma gesellschaft m.b.h, austria - buprenorfīns - transdermālais plāksteris - 20 mikrogrami/stundā